Vasopressin-stimulated movement of drugs and uric acid across the toad bladder. Vasopressin is known to increase the permeability of the toad bladder, an analogue of the mammalian collecting duct, to water and hydrophilic solutes such as urea. In the present study, the effect of vasopressin on the permeability of a series of lipophilic compounds, including many commonly used drugs, has been determined. In all cases, permeability increased from 50 to 100%. The response to vasopressin was mediated by cyclic adenosine monophosphate (cAMP), and was generally not altered by phloretin, an agent that inhibits amide movement through the amide transport pathway. Evidence that these compounds move directly through the lipid phase of the membrane was provided in studies of phenobarbital permeability at low and high luminal pH. We would conclude from these studies that the effect of vasopressin on the luminal cell membrane is a widespread one, modifying both lipid components and components involved in amide, sodium and water transport. This may be of importance in the renal tubular reabsorption of many drugs, including barbiturates, glutethimide and antibiotics. 
30
solutes as well, with compounds such as caffeine increasing their permeability by 30% following administration of the hormone. This finding is of particular interest in relation to the effect of vasopressin on the renal reabsorption of commonly used drugs, many of which are highly lipophilic. We have therefore determined the effect of vasopressin on the movement of a series of therapeutic agents and other lipophilic solutes across the toad bladder, and have found that vasopressin accelerates the movement of all solutes tested. This is of interest not only in relation to drug metabolism, but in relation to the mechanism of action of vasopressin on the cell membrane.
Methods
Female toads (National Reagents, Bridgeport, CT) were doubly pithed, and glass bungs tied into both hemibladders in situ. The bladders were removed and filled with 8 ml of phosphate-buffered Ringer's solution (120 m Nat; 4.0 mvi K; 0.5 mM Ca; 116 m Cl-; mrvi phosphate, pH 7.4; 230 mOsm/kg of H20). The bladders were washed inside and out three times with fresh Ringer's to remove any endogenous vasopressin, and were finally refilled with 8 ml of Ringer's containing the isotope to be tested. The bladders were then suspended in 30 to 35 ml of Ringer's. Stirring was provided by magnetic stirrers inside and out for the more permeable compounds (baseline Ktrans > 20 X 10 cm/sec) to minimize the effect of unstirred layers on measured permeability [6] .
Where osmotic water flow was to be determined, Ringer's diluted 1:10 with distilled water was substituted for the full-strength Ringer's in the luminal washes and bath. In studies with phenobarbital, Ringer's buffered by 4 mrst phthalate to pH 5.0, or 5 mM Tris to pH 9.0, was substituted for the phosphate Ringer's in the luminal washes and bath. Fullstrength phosphate Ringer's, pH 7.4, was always used for the serosal washes and bath. The permeability of 14C-butanol was measured in the mechanically stirred Lucite chambers previously described [6] , in order to minimize the effects of unstirred layers on this very permeable compound. The permeability coefficient (Ktrans) of each isotopic species was determined by sampling the serosal and luminal bathing media at timed intervals [4] . Samples were pipetted into Aquasol (New England Nuclear Corp., Boston, MA) and counted in a liquid scintillation counter (Tri-Carb, Packard Instrument Co., LaGrange, IL. Water movement was determined by carefully blotting the bags and weighing them [7] . '4C-5-fluorouracil and cyclohexanone were obtained from the International In all experiments, results obtained in test hemibladders were compared with those from control hemibladders by the method of paired analysis [8] . Verification of the purity of the isotope appearing in the serosal bath was obtained by thin-layer chromatography for phenobarbital [9] , diphenylhydantoin [10] and glutethimide [9] . Dr. Ruth Abramson determined the purity of the '4C-uric acid [11] . Decanol: water partition coefficients (Kdec) for the isotopes tested were measured by the method of Tosteson et al [12] .
Results
Compounds tested. The compounds investigated are shown in Fig. 1 , together with their decanol: water partition coefficients (Kdec). A low Kôec (e.g., uric acid) indicates far greater solubility in water than in decanol; a high Kdec (e.g., phenobarbital, glutethimide, diphenylhydantoin) indicates the opposite. The compounds tested included three amides: tetracycline, chloramphenicol and isoniazid; five imides (ring compounds in which a nitrogen adjoins a carbonyl): uric acid, fluorouracil, phenobarbital, glutethimide and diphenylhydantoin; and three compounds which are unrelated to either of these two groups:
adenine, butanol and cyclohexanone. mm period. Ktrans butanol was measured in chambers for one 20-mm baseline and one 20-mm experimental period. The effect of vasopressin on the permeability of the compounds tested is shown in Table  I . All of the compounds tested showed a significant increase in permeability after vasopressin. The increase in permeability ranged from 13% for butanol to 140% for diphenylhydantoin, and was seen even in the most lipid-soluble molecules tested. Effect of cyclic AMP and theophylline on diphenylhydantoin permeability. To determine whether the post-vasopressin increase in permeability of the lipidsoluble substances tested is, like that of amides and water, mediated by increased formation of adenosine 3',5'-cyclic monophosphate (cyclic AMP), the effect of this nucleotide on Ktrana diphenylhydantoin was determined. After measurement of Ktrang diphenylhydantoin for a 15-mm baseline period (period I, Table  2 ), the serosal bath of the test hemibladders was replaced with Ringer's containing 10 m cyclic AMP, and Ktrans determined for an additional 30-mm period (period II). Control hemibladders were treated similarly, but received no cyclic AMP. A significant increase in Ktrana diphenylhydantoin was seen in the test bladders after cyclic AMP administration.
In order to determine whether maximal stimulation by cyclic AMP was comparable to the effect of vasopressin, an additional series of experiments was performed in which the test bladders received 3 mM theophylline in addition to 10 m cyclic AMP at the end of period I. As shown in the bottom of Table 2 , cyclic AMP and theophylline caused an approximate doubling of Ktrans diphenylhydantoin, an effect comparable to that of 86 mU/ml of vasopressin.
The effect of alteration of lipid solubility on Ktrans phenobarbital. To be certain that the permeabilities of the compounds tested, both before and after vasopressin administration, represented their movement through the lipid rather than the aqueous phase of the membrane, experiments were performed in which the lipid solubility of 14C-phenobarbital was altered by reducing the pH of the luminal bath to 5.0, or raising it to 9.0. The concentration of the lipid-soluble or nonionized form of phenobarbital is markedly altered by this change in PH; at pH 5.0, phenobarbital, which has a pK of 7.3, is over 99% in the lipid-soluble form, and Kôecanoi is 17.5; at pH 9.0, only 2% is nonionized, and Kdecanol is only 0.5. As shown in Fig. 2 , both baseline and vasopressin-stimulated phenobarbital permeabilities changed in parallel with lipid solubility, suggesting that lipid solubility was indeed the major determinant of transport both before and after vasopressin administration. The absence of effect of pH on the movement of glutethimide (which has a pK of 11.8, so that the proportion of the nonionized form is high even at pH 9), and on urea and osmotic water flow, suggests that the decrease in phenobarbital permeability at pH 9 can be attributed to alterations in lipid solubility of the phenobarbital, and not to changes in the bladder induced by high pH.
The effect of phloretin on isotope permeability. Previous studies [13] have shown that phioretin, the aglucone of phlorizen, blocks the transport of amides, and certain nonamides (thiourea and formaldehyde) across the toad bladder. The effect of phloretin on the movement of isoniazid, phenobarbital, glutethimide and diphenylhydantoin was therefore determined. (6) Adenine (5) 5-Fluorouracil (4) Tetracycline (4) Chloramphenicoi (4) lsoniazid (4) Phenobarbital (6) Diphenylhydantoin (4) Glutethimide (6) Cyclohexanone (5) N-Butanol(5) Test hemibladders contained l04M phloretin in 0.5% ethanol added to the luminal bath. Control hemibladders received 0.5% ethanol alone. Figure 3 shows the effect of phloretin on the isotopes tested after the addition of vasopressin, as well as on other isotopes tested previously [13] . Of the compounds tested in the present study, only the permeability of the amide isoniazid was depressed by phloretin, while permeabilities of the non-amides were unaltered.
Discussion
The present study shows that vasopressin increases the permeability of the toad urinary bladder to every compound tested, from uric acid (virtually insoluble in lipid) to highly lipid-soluble compounds such as glutethimide, cyclohexanone and butanol.
Our findings have several implications for our understanding of the mechanism of action of vasopressin. First, in contrast to earlier proposals that vasopressin opens aqueous channels in the luminal membrane, permitting water and small hydrophilic solutes to penetrate the membrane at a more rapid rate [2, 14] , the present findings support the view that the hormonal effect is a widespread one, which may transform both the lipid and protein phases of the membrane. Earlier studies have shown that independent membrane pathways exist for water, amides and non-amides in the vasopressin-treated toad bladder [3, 13] . We now would add a cyclic AMP-mediated pathway for highly lipophilic solutes, suggesting that the fluidity of the entire lipid phase of the luminal membrane may be altered by vasopressin [5] . We may therefore view the action of the hormone as both a broad one with respect to membrane lipid, in which the permeability to lipophilic molecules increases +100 - nonselectively from 50 to 100%, and a more specific one with respect to the transport pathway for amides such as urea, whose permeability may increase by ten-fold. Pietras and Wright [5] have suggested that a change in the fluidity of the membrane lipid might account for the increased permeability of both lipophilic and hydrophilic solutes if, for example, vasopressin caused a relatively larger increase in the fluidity at the polar head groups of the lipid than in the hydrophobic "core" of the membrane. The fact that phloretin, which inhibits amide transport, has no detectable effect on the permeability of lipophilic solutes' points to a second possibility: that phioretin (as well as tannic acid and chromate [15]) blocks a protein pathway through the membrane which is parallel to the pathway for lipophilic solutes. In synthetic lipid bilayers, phioretin increases the permeability of the amide acetamide by two-fold, rather than decreasing it (Finkelstein A., unpublished observations), providing additional evidence that amide movement across the toad bladder does not proceed through a simple lipid barrier. As far as water and sodium transport are concerned, the role of vasopressin-induced changes in membrane lipid is not established. The failure to detect a generalized vasopressin effect in prior experiments [161 was probably due to edge damage associated with the Lucite chambers used in these studies [17] , so that a small vasopressin effect could have been obscured by the leak at the bladder edge. The present bag preparations have a considerably higher surface area-to-edge ratio and thus would tend to be less affected by edge damage.
In addition, unstirred layers in the magnetically stirred bags may be less important than in the chambers which were stirred by air-lift only.
Turning to clinical implications of this study, our findings suggest, by analogy, that vasopressin enhances distal nephron reabsorption of drugs in man. This would have no detectable effect on the clearance of a compound such as uric acid, whose permeability across the toad bladder is virtually zero both before and after vasopressin administration; however, the clearance of more permeable molecules such as diphenylhydantoin and glutethimide would be expected to be lower in the presence than in the absence of vasopressin. Our results support the accepted clinical practice of maintaining high urine flows in patients with drug overdose, and suggest in addition that renal reabsorption of agents such as glutethimide and phenobarbital may be further depressed if vasopressin levels are low. This possible advantage must, ' Owen and Solomon [18] have reported a significant enhancement of the permeability of lipophilic molecules across the erythrocyte membrane by phloretin; this was not apparent in the toad bladder.
of course, be weighed against the danger of fluid overload in such patients.
